News
MIT researchers find statistical approach to COVID-19 clinical trials that can accelerate drug approval process
MIT researchers have developed a framework that uses an epidemiological model of COVID-19 to calculate the optimal statistical threshold for approving a drug during a pandemic
Sandoz responds to increased demand for antibiotics and other essential medicines for patients during COVID-19
Sandoz has so far managed to ensure a dependable supply of medicines through swift action to increase production in the face of rapidly surging demand and multiple new obstacles throughout the supply chain.
Moderna’s COVID-19 vaccine shows positive results in phase 1 clinical trials
“With these positive interim Phase 1 data and the positive data in the mouse challenge model, the Moderna team continues to focus on moving as fast as safely possible to start our pivotal Phase 3 study in July and, if successful, file a BLA,” said Dr Stéphane Bancel, CEO, Moderna.
voice for BT and BEST 2026
